Colleen Cutcliffe is the CEO and co-founder of Pendulum Therapeutics, with several programs in the clinical phase. Colleen has over 20 years of experience leading teams in biotech, pharma, and academia. She also serves as the Chair of the BOD of the California Life Science Institute and serves on the leadership board of the American Diabetes Association.